Back
Open Access

Prognosis of mitral valve regurgitation and left ventricular function in dual coronary repair for anomalous origin of left coronary artery from pulmonary artery (ALCAPA)

Session: Cardiovascular Surgery ePosters
Topic: Congenital Heart Disease
Speaker: Doctor S. Kotit (Aswan, EG)
Event: ESC Congress 2021 - The Digital Experience

Congress Session

0

About the speaker

Doctor Susy Kotit

Aswan Heart Centre, Aswan (Egypt)
0 follower

23 more presentations in this session

Right ventricular diastolic dysfunction and postoperative cardiac complications in patients undergoing coronary artery bypass grafting

Speaker: Professor A. Sumin (Kemerovo, RU)

Access
Abstract
Slides
0
Thumbnail

Early results of multiple coronary artery bypass grafting on arteries less than 1.5 mm in diameter

Speaker: Mr V. Zaikovskii (Moscow, RU)

Access
Abstract
Slides
0
Thumbnail

Percutaneous access versus surgical cutdown in TAVI: vascular and bleeding complications.

Speaker: Doctor K. Stathogiannis (Stanford, US)

Access
Abstract
Slides
0
Thumbnail

Preoperative anaemia is an independent predictor of 30-day mortality post-CABG and improves de predictive accuracy of EuroScore II

Speaker: Doctor A. Rosler (Porto Alegre, BR)

Access
Abstract
Slides
0
Thumbnail

EuroScore II is the best predictive model for the off pump coronary artery bypass graft surgery

Speaker: Doctor A. Rosler (Porto Alegre, BR)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Cardiovascular Surgery ePosters

Speakers: Doctor S. Kotit, Professor A. Sumin, Mr V. Zaikovskii, Doctor K. Stathogiannis, Doctor A. Rosler...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

Open Access

Successful Transcatheter Occlusion of a Left Ventricular Outflow Tract Pseudoaneurysm Using a «Plug and Coil» Strategy.

27 August 2021

Open Access

Severe biventricular myocardial involvement in Systemic sclerosis.

27 August 2021

Open Access

The HEP-COVID Trial

27 August 2021

This platform is supported by

logo Novo Nordisk